glp 1 microdose tirzepatide Microdosing and Semaglutide for Weight Loss Compounded TIRZEPATIDE (GLP-1 + GIP)

In September 2019, the first oral GLP-1R agonist for T2D was approved by FDA (Mosenzon et al., 2019

Brellos pricing is lower than most competitors because the program is standardized and billed in multi-month cycles

At first, this might seem like a downside after all, clinical research has reliably shown that less than 1% of all orally ingested berberine ends up circulating in the bloodstream40 but then you recognize that berberine studies typically do not use bioenhanced forms

We invested in a bFan, and it changed everything

Gland is also preparing for a larger play in the biologics business, focusing on expanding its biosimilar and biologic CDMO segment